Stocks
23776SNBC
YHDHealthcareBiotechnology
A biopharmaceutical company focused on developing therapies for rare diseases, with a pipeline targeting genetic disorders. Its lead candidates are in early-to-mid stage clinical trials, and investors track it for potential orphan drug approvals and partnership opportunities.
Congressional Interest in 23776 (SNBC)
2 members of Congress have disclosed 2 trades in 23776 (SNBC), a Healthcare company. The buy/sell breakdown shows 2 purchases versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
2
Unique Politicians
2
Buys
2
Sells
0
Who in Congress Is Trading SNBC?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2015-06-07 | KENNY MARCHANT | buy | $1K-$15K |
| 2010-03-03 | Vern Buchanan | buy | $1K-$15K |